EVOZARE Trademark

Trademark Overview

On Thursday, June 9, 2016, a trademark application was filed for EVOZARE with the United States Patent and Trademark Office. The USPTO has given the EVOZARE trademark a serial number of 87066081. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 8, 2019. This trademark is owned by Allergan Pharmaceuticals International Limited. The EVOZARE trademark is filed in the Pharmaceutical Products category with the following description:

Oral pharmaceutical preparations for the treatment of acne
evozare

General Information

Serial Number87066081
Word MarkEVOZARE
Filing DateThursday, June 9, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 8, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2016

Trademark Statements

Goods and ServicesOral pharmaceutical preparations for the treatment of acne

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 16, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllergan Pharmaceuticals International Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCoolock, Dubin 17
IE
Party NameAllergan Pharmaceuticals International Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCoolock, Dubin 17
IE

Trademark Events

Event DateEvent Description
Monday, July 8, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 8, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, November 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 1, 2018EXTENSION 4 GRANTED
Thursday, November 1, 2018EXTENSION 4 FILED
Thursday, November 1, 2018TEAS EXTENSION RECEIVED
Thursday, May 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 15, 2018EXTENSION 3 GRANTED
Tuesday, May 15, 2018EXTENSION 3 FILED
Tuesday, May 15, 2018TEAS EXTENSION RECEIVED
Friday, November 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 1, 2017EXTENSION 2 GRANTED
Wednesday, November 1, 2017EXTENSION 2 FILED
Wednesday, November 1, 2017TEAS EXTENSION RECEIVED
Thursday, May 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 2, 2017EXTENSION 1 GRANTED
Tuesday, May 2, 2017EXTENSION 1 FILED
Tuesday, May 2, 2017TEAS EXTENSION RECEIVED
Tuesday, January 17, 2017ASSIGNED TO EXAMINER
Tuesday, December 6, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 11, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2016PUBLISHED FOR OPPOSITION
Wednesday, September 21, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 2, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 1, 2016ASSIGNED TO EXAMINER
Thursday, June 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 13, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

evozare acne treatment preparations pharmaceutical oral